Obesity and its nurturing effect on hepatitis C

被引：26

作者：

McCullough, AJ

机构：

[1] Case Western Reserve Univ, Metrohlth Med Ctr, Div Gastroenterol, Cleveland, OH 44109 USA

[2] Case Western Reserve Univ, Metrohlth Med Ctr, Schwartz Ctr Metab & Nutr, Cleveland, OH 44109 USA

来源：

HEPATOLOGY | 2003年 / 38卷 / 03期

关键词：

D O I：

10.1053/jhep.2003.50413

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：557 / 559

页数：3

共 17 条

[1] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity [J].

Adinolfi, LE ;

Gambardella, M ;

Andreana, A ;

Tripodi, MF ;

Utili, R ;

Ruggiero, G .

HEPATOLOGY, 2001, 33 (06) :1358-1364

[2]

Banerjee D, 2001, ANN ROY COLL SURG, V83, P268

[3] High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C [J].

Bressler, BL ;

Guindi, M ;

Tomlinson, G ;

Heathcote, J .

HEPATOLOGY, 2003, 38 (03) :639-644

[4] PREDICTION OF THE RESPONSE OF CHRONIC HEPATITIS-C TO INTERFERON-ALFA - A STATISTICAL-ANALYSIS OF PRETREATMENT VARIABLES [J].

CAMPS, J ;

CRISOSTOMO, S ;

GARCIAGRANERO, M ;

RIEZUBOJ, JI ;

CIVEIRA, MP ;

PRIETO, J .

GUT, 1993, 34 (12) :1714-1717

[5] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[6] Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C [J].

Hickman, IJ ;

Clouston, AD ;

Macdonald, GA ;

Purdie, DM ;

Prins, JB ;

Ash, S ;

Jonsson, JR ;

Powell, EE .

GUT, 2002, 51 (01) :89-94

[7] Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis [J].

Hourigan, LF ;

Macdonald, GA ;

Purdie, D ;

Whitehall, VLJ ;

Shorthouse, C ;

Clouston, A ;

Powell, EE .

HEPATOLOGY, 1999, 29 (04) :1215-1219

[8] Effect of obesity on pharmacokinetics and biologic effect of interferon-α in hepatitis C [J].

Lam N.P. ;

Pitrak D. ;

Speralakis R. ;

Lau A.H. ;

Wiley T.E. ;

Layden T.J. .

Digestive Diseases and Sciences, 1997, 42 (1) :178-185

[9]

Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x

[10] Lower Th-1/Th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C [J].

Masaki, N ;

Fukushima, S ;

Hayashi, S .

DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (10) :2163-2169

← 1 2 →